Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Charles Broderick who wrote (11073)	11/28/1998 1:17:00 PM
From: Ron Luhmann	Read Replies (1) \| Respond to of 14328

Sharewatcher ... the shorting of shares isn't TRIBY's lament(see post 11064) ... the relative few shares short just doesn't support that hypothesis ... From several long TRIBY shareholders that have discussed this topic at great length for the past 3-4 years: TRIBY's lack of U.S. market exposure, (now OTC's responsibility), Brokerage coverage (Major House), Fund/Inst investment ($3/share market listing requirement to stabilize share price & evaporate the float) and most of all FDA UNIGOLD stamp of approval with PROPER MARKET INTRODUCTION FANFARE!! ... should propel TRIBY to her proper place in the stratosphere of Biotech success stories !! It's not far away Tribites !! UNIGOLD technology approval "STREP A" is close at hand followed by a long line of TRIBY FDA 510k "substantially equivalent" product submissions (these now have a 90day time limit for approval barring FDA need for additional info) !! GO TRIBY !! Merry Christmas !! ... :-) Ron